Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Capital Expenditures (2016 - 2025)

Vanda Pharmaceuticals' Capital Expenditures history spans 15 years, with the latest figure at $102000.0 for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 52.34% to $102000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $998000.0, a 103.67% increase, with the full-year FY2025 number at $998000.0, up 103.67% from a year prior.
  • Capital Expenditures hit $102000.0 in Q4 2025 for Vanda Pharmaceuticals, down from $161000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for VNDA hit a ceiling of $436000.0 in Q1 2025 and a floor of -$10000.0 in Q3 2021.
  • Historically, Capital Expenditures has averaged $155100.0 across 5 years, with a median of $141000.0 in 2021.
  • Biggest five-year swings in Capital Expenditures: tumbled 104.07% in 2021 and later surged 6128.57% in 2025.
  • Tracing VNDA's Capital Expenditures over 5 years: stood at $134000.0 in 2021, then surged by 96.27% to $263000.0 in 2022, then fell by 3.8% to $253000.0 in 2023, then decreased by 15.42% to $214000.0 in 2024, then tumbled by 52.34% to $102000.0 in 2025.
  • Business Quant data shows Capital Expenditures for VNDA at $102000.0 in Q4 2025, $161000.0 in Q3 2025, and $299000.0 in Q2 2025.